HALOPERIDOL PLASMA-LEVEL AFTER A TEST DOSE AS PREDICTOR FOR THE CLINICAL-RESPONSE TO TREATMENT IN ACUTE SCHIZOPHRENIC-PATIENTS

被引:7
|
作者
NETO, MRL [1 ]
MULLERSPAHN, F [1 ]
RUTHER, E [1 ]
SCHERER, J [1 ]
机构
[1] UNIV MUNICH, PSYCHIAT HOSP, D-8000 MUNICH 2, FED REP GER
关键词
D O I
10.1055/s-2007-1014680
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:226 / 231
页数:6
相关论文
共 50 条
  • [21] NEUROLEPTIC SERUM LEVELS MEASURED BY RADIORECEPTOR ASSAY AND CLINICAL-RESPONSE IN SCHIZOPHRENIC-PATIENTS
    TUNE, LE
    CREESE, I
    DEPAULO, JR
    SLAVNEY, PR
    SNYDER, SH
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1981, 169 (01) : 60 - 63
  • [22] RELATION OF PLASMA PROLACTIN TO CLINICAL RESPONSE IN SCHIZOPHRENIC-PATIENTS
    GRUEN, PH
    SACHAR, EJ
    ALTMAN, N
    LANGER, G
    TABRIZI, MA
    HALPERN, FS
    ARCHIVES OF GENERAL PSYCHIATRY, 1978, 35 (10) : 1222 - 1227
  • [23] STEADY-STATE PLASMA-LEVEL PREDICTION FOR HALOPERIDOL FROM A SINGLE TEST DOSE
    JAVAID, JI
    JANICAK, PG
    HEDEKER, D
    SHARMA, RP
    DAVIS, JM
    PSYCHOPHARMACOLOGY BULLETIN, 1991, 27 (01) : 83 - 88
  • [24] PLASMA-LEVEL PROFILES AND CLINICAL-RESPONSE OF PENBUTOLOL AFTER 3 DIFFERENT SINGLE ORAL DOSES IN MAN
    JUN, HW
    HAYES, SL
    VALLNER, JJ
    HONIGBERG, IL
    ROJOS, AE
    STEWART, JT
    JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 19 (8-9): : 415 - 423
  • [25] PROLACTIN RESPONSE TO HALOPERIDOL TREATMENT IN SCHIZOPHRENIC-PATIENTS AS AN INDEX OF ITS ANTIPSYCHOTIC EFFECT
    ELIZUR, A
    SEGAL, Z
    YERET, A
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1980, 16 (03): : 222 - 222
  • [26] PLASMA-LEVEL, DOSE, AND CLINICAL SYMPTOMATOLOGY IN ACUTE DIPHENHYDRAMINE POISONING
    KOPPEL, C
    TENCZER, J
    IBE, K
    VETERINARY AND HUMAN TOXICOLOGY, 1987, 29 : 37 - 37
  • [27] COMPUTERIZED EEG TOPOGRAPHY FINDINGS IN SCHIZOPHRENIC-PATIENTS BEFORE AND AFTER HALOPERIDOL TREATMENT
    KEMALI, D
    GALDERISI, S
    MAJ, M
    MUCCI, A
    DIGREGORIO, M
    BUCCI, P
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 1992, 13 (03) : 283 - 290
  • [28] REDUCED HALOPERIDOL PLASMA-CONCENTRATION AND CLINICAL-RESPONSE IN ACUTE EXACERBATIONS OF SCHIZOPHRENIA
    KELLY, MW
    PERRY, PJ
    CORYELL, WH
    MILLER, DD
    ARNDT, SV
    PSYCHOPHARMACOLOGY, 1990, 102 (04) : 514 - 520
  • [29] A DOSE-FINDING STUDY WITH REMOXIPRIDE IN THE ACUTE TREATMENT OF SCHIZOPHRENIC-PATIENTS
    LAPIERRE, YD
    ANCILL, R
    AWAD, G
    BAKISH, D
    BEAUDRY, P
    BLOOM, D
    CHANDRASENA, R
    DAS, M
    DURAND, C
    ELLIOTT, D
    HORN, E
    JONES, B
    MANCHANDA, R
    MAX, P
    MCCLURE, DJ
    RAVINDRAN, A
    ROTSTEIN, E
    SANDOR, P
    SAXENA, B
    SLADENDEW, N
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1992, 17 (04): : 134 - +
  • [30] PUPILLARY CONSTRICTION DURING HALOPERIDOL TREATMENT AS A PREDICTOR OF RELAPSE FOLLOWING DRUG-WITHDRAWAL IN SCHIZOPHRENIC-PATIENTS
    STEINHAUER, SR
    VANKAMMEN, DP
    COLBERT, K
    PETERS, JL
    ZUBIN, J
    PSYCHIATRY RESEARCH, 1992, 43 (03) : 287 - 298